# Humira

Type: Product

Source: Supply Chain Intelligence Brief — https://getsupplybrief.com/entity/humira
Canonical HTML page: https://getsupplybrief.com/entity/humira

## Timeline

- **2029-01-01**: Operational Launch — The new facilities are expected to come online and begin API production.
- **2026-03-21**: Construction Start — Anticipated groundbreaking for the two new manufacturing plants.
- **2026-02-23**: Manufacturing Expansion — AbbVie announces $380 million investment for North Chicago API facilities.
- **2026-01-12**: $100B Pledge — AbbVie commits to $100 billion in U.S. R&D and capital investments over the next decade.

## Recent coverage (1 stories)

### AbbVie Commits $380M to U.S. API Production in $100B Supply Chain Pivot
2026-02-25 00:13:32 · Sentiment: Positive · Impact: 7/10 · Sources: 3

AbbVie has announced a $380 million investment to expand active pharmaceutical ingredient (API) manufacturing in North Chicago, marking the first major step in a $100 billion decade-long commitment to U.S. R&D and production. The move aligns with federal efforts to reshore critical drug supply chains and lower costs through direct-to-patient channels like TrumpRx.
Full story: https://getsupplybrief.com/story/abbvie-380m-us-manufacturing-investment

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getsupplybrief.com/guides/methodology for the full editorial methodology.